Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer

Clinical trial NCT06601296 · RECRUITING

Trial details

NCT number: NCT06601296
Sponsor: University of Texas Southwestern Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Renal Cell Carcinoma ( mRCC)OligoProgressive Metastatic Disease

Start date: 2025-04-01
Primary completion: 2027-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.